Other languages Chordate Medical Holding AB

Equities

CMH

SE0009495559

Market Closed - Nasdaq Stockholm Other stock markets 09:30:00 27/06/2024 pm IST			5-day change	1st Jan Change
0.0632 ^SEK	-15.73%		+17.04%	-60.60%

13/06	Chordate Medical Holding AB Enters New Partnership Agreement with Neurolite AG	CI
13/06	Chordate Medical Holding AB (OM:CMH) signed an agreement to acquire Neurolite.	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Chordate Medical Holding AB Enters New Partnership Agreement with Neurolite AG	13/06
Chordate Medical Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	24/05
Chordate Medical Receives Patent Approval in the US	07/05
Chordate Medical Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	22/03
Chordate Medical Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/03
Chordate Medical Gains EU Patent for Chronic Migraine Treatment	02/02
Chordate Medical Holding AB Announces the European Patent Office Grants New Patent	02/02
Chordate Medical Holding AB Signs Agreement with German Clinic for the Ozilia Treatment for Chronic Migraine	30/01
Chordate Medical Completes Training of Clinic Staff and Assists in Initiation of Treatment for First Three Patients at the Private Clinic in Hamburg	10/01
Chordate Medical Holding AB Announces First Patients Included in the Post-Market Study PM010	21/12
Chordate Medical Holding AB Announces First Patient Included in the Company's Open Pilot Study PM009	04/12
Chordate Medical Holding AB Receives First Installation of the Ozilia Migraine Treatment at a Private Clinic in Hamburg	28/11
Chordate Medical Holding AB Announces Post-Market Study of Chordate's Ozilia® Migraine Treatment Has Commenced in Four Different Markets	10/11
Chordate Medical Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	01/11
Chordate Medical Trademarks Migraine Treatment Ozilia in EU	27/23/27
Chordate Medical Receives Registration of the Tradark Ozilia	27/23/27
Chordate Medical Holding AB Introduces New Trademark for Migraine Treatment: Ozilia? - Migraine Relief	11/23/11
Chordate Medical Holding AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	31/23/31
Chordate Medical Holding AB Announces Complete Study Results from Migraine Study Submitted to Scientific Journal	21/23/21
Otto Skolling Elected to Chordate Medical's Board	15/23/15

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Chordate Medical Holding AB

Equities

CMH

SE0009495559

Other languages

Filters